The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Novartis (Inst)

The effect of gastrectomy in regorafenib treated GIST patients on outcome and drug exposure.
 
Nielka P. Van Erp
Research Funding - Astellas Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Floor Lubberman
No Relationships to Disclose
 
Winette T.A. Van Der Graaf
No Relationships to Disclose
 
Lei Xu
Employment - Bayer
 
Adriaan Cleton
Stock and Other Ownership Interests - Bayer; Bayer
 
Hans Gelderblom
Patents, Royalties, Other Intellectual Property - Amgen, Boehringer-Ingelheim, Pfizer, Novartis, Pharmamar, Daiichi, Five Prime (Inst)
Other Relationship - Daiichi Sankyo